[1]
I. S. Nosulenko, O. Y. Voskoboynik, O. M. Antypenko, G. G. Berest, and S. I. Kovalenko, “Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies”, Zaporozhye Medical Journal, vol. 17, no. 1, Feb. 2015.